Biolase (BIOL) Tops Q3 EPS by 2c

Biolase (NASDAQ: BIOL) reported Q3 EPS of ($0.07), $0.02 better than the analyst estimate of ($0.09). Revenue for the quarter came in at $12.7 million versus the consensus estimate of $11.7 million.

For earnings history and earnings-related data on Biolase (BIOL) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• SuperCom (SPCB) Tops Q3 EPS by 43c
• SanDisk unveils long-term growth strategy at 2026 Investor Day; Shares surge 12%